Best Healthcare Companies in United Kingdom
The 4198 best Healthcare companies in United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: IVC Evidensia.
Healthcare companies in the United Kingdom don't lack for ambition, and this directory of 4,198 tracked firms ranked by disclosed equity funding makes the scale of that ambition legible. Total disclosed funding across the cohort sits at $16.7B, and one name accounts for a disproportionate share of it: AstraZeneca has filed $4.1B, a figure that dwarfs Oxford BioMedica's $150M and leaves the rest of the pack, Abingdon Health at $24M, Biofortuna at $22M, well back in the field. The global market these companies are competing in is forecast to reach $2.6 trillion by 2025, growing at a 6.3% CAGR, driven by virtual care preferences and demand for more affordable delivery models. Strict compliance to product safety adds friction for every filer here, but it also raises the floor on credibility.
So what's actually moving inside the sector right now? Hot research themes are concentrated tightly around vaccine candidates, vaccine trials, and immunogenicity, and as shown in 2017 research, trial design quality directly shapes how those results translate to real-world outcomes. Digital health is pulling its weight too: median app install growth across hospital and healthcare apps runs at roughly 16% year-on-year across 53 tracked titles. I'd point you toward the investor mix as a signal of where conviction lives, with BGF, HSBC, and the Northern Powerhouse Investment Fund all active across the directory. The funding is real, the revenue upside is measurable, and the companies here earned their rankings the hard way.
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
Ranked: Best Healthcare companies in United Kingdom
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IVC Evidensia Chains that provide animal veterinary medical care and clinical services | $4.7B | 60 mo ago | Acquired | 28,000 | Simon Smith Group CEO | — | — | — |
| 2 | AstraZeneca Developer of pharmaceutical medicines for oncology and various chronic diseases | $4.1B | 11 mo ago | Public | 83,100 | Pascal Soirot CEO | 99 signals ▼20% Earnings · Hiring · Capital raise | 2,898 patents Antibody therapeutics and ADCs for oncology and viral diseases, especially SARS‑CoV‑2. | — |
| 3 | PureGym Chain of fitness centers | $412M | 32 mo ago | Acquired | 3,247 3,247 → 3,893 (+20%) · sector median +44% | — | — | — | 1 job opening · 1 expansion |
| 4 | Almac Group CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic… | $339M | 45 mo ago | Series D | 2,109 2,109 → 4,895 (+132%) · sector median +44% | Alan Armstrong CEO & Chairman | 10 signals ▲400% Capital raise · Announcements · New product | — | 1 award |
| 5 | International SOS Provider of a digital for protecting global workforces from health and security threats | $306M | 30 mo ago | Late Stage | 451 | Arnaud Vaissie Co-Founder | — | 5 patents Maritime man‑over‑board detection systems using onboard sensor technologies | — |
| 6 | Oxford BioMedica Manufacturer of viral vectors for cell and gene therapy products | $150M | 10 mo ago | Public | 815 815 → 933 (+14%) · sector median +44% | Neill Mackenzie Founder | 12 signals Earnings · Funding · Announcements | 427 patents Lentiviral vector design, production, and purification for gene‑therapy applications | — |
| 7 | Meallmore Provider of senior nursing care home services | $142M | 27 mo ago | Funding Raised | 1,700 | — | — | — | 2 expansions |
| 8 | SynOx Manufacturer of drugs | $136M | 19 mo ago | Series B | 10 | — | — | — | — |
| 9 | Third Space London Chain of health and fitness clubs | $108M | 32 mo ago | Acquired | 87 | John Penny CEO & MD | — | — | 1 partnership · 1 expansion |
| 10 | Randox Instruments and assays for clinical diagnostics | $69M | 11 mo ago | Funding Raised | 200 | Peter Fitzgerald Founder | — | — | — |
| 11 | Medik8 Provider of premium skincare products and personalized skincare regimens | $55M | 23 mo ago | Acquired | 100 | Elliot Isaacs Founder | — | 5 patents Stabilizing and delivering sensitive cosmetic actives in skin‑care formulations | 1 launch · 1 award |
| 12 | Bridge Farm Bioscience Provider of cannabis plant research and development company | $49M | 26 mo ago | Seed | 167 | Louise Motala CEO | — | — | — |
| 13 | Curve Therapeutics Developer of Microcycle-based therapeutics addressing intracellular targets for cancer and inflammation | $47M | 27 mo ago | Series A | 14 | Simon Kerry Chief Executive Officer | — | — | 1 launch |
| 14 | Ennogen Pharmaceutical and medical device company manufacturing API | $37M | 25 mo ago | Funding Raised | — | John Ruprai Founder & CEO | — | — | — |
| 15 | Cinnamon Care Collection Provider of nursing home, residential and respite care services | $32M | 17 mo ago | Funding Raised | 243 | — | — | — | 2 expansions · 1 award |
| 16 | Abingdon Health Developer of immunoassays for diagnostic purposes 57Funding top 29%Growth top 33%Market top 46%Moat top 48% All 7 signals ▾Fundingtop 29% Growthtop 33% Markettop 46% Moattop 48% Techbottom 49% Newsbottom 40% Globalbottom 32% Funding: Raised $24.1M across 8 rounds · 8 rounds over 14 yrs (0.6/yr) Growth: Headcount 51 → 151 (+196%) across vintages · 2 acquisition/expansion moves in 24 mo rank vs industry peers · Fliar Intelligence Index 57/100 | $24M | 8 mo ago | Public | 151 151 → 91 (-40%) · sector median +44% | — | 3 signals ▼67% Earnings | — | 2 awards |
| 17 | Lindus Health Provider of contract based clinical trial & recruitment services | $23M | 16 mo ago | Series B | 7 | Michael Young Co-Founder & Co-CEO | 3 signals Leadership | — | — |
| 18 | Biofortuna Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services | $22M | 3 mo ago | Series A | 32 32 → 31 (-3%) · sector median +44% | Katherine Douglas Co-Founder | — | 9 patents Molecular diagnostic reagents and kits for PCR amplification and tissue‑typing assays | — |
| 19 | Seda Provider of consulting services to biopharma sector | $20M | 3 mo ago | Series B | — | Paul Dickinson Founder and CSO | — | — | 2 job openings · 1 award |
| 20 | Hexarad Provider of radiology laboratory center services | $19M | 22 mo ago | Series B | 8 | Jaymin Patel Co-Founder | — | — | 1 job opening |
| 21 | Elder Marketplace for senior care services | $19M | 25 mo ago | Series B | 129 129 → 240 (+86%) · sector median +44% | Peter Dowds Co-Founder | — | — | — |
| 22 | Panthera Clinical trials organization providing site management and patient recruitment services to pharmaceutical and… | $16M | 10 mo ago | Late Stage | 66 | John Lyon Co-Founder & Chairman | — | 4 patents Provides modular support blocks for temporary construction hoarding systems | 1 award |
| 23 | Audiologicalscience Provider of hearing aid services and ear wax removal | $16M | 15 mo ago | Acquired | — | — | — | — | — |
| 24 | GPDQ Online platform booking doctors for house call 40Innovation top 34%Growth top 35%Product top 36%Moat top 39% All 9 signals ▾Innovationtop 34% Growthtop 35% Producttop 36% Moattop 39% Fundingtop 45% Talentbottom 49% Techbottom 40% Globalbottom 37% Marketbottom 23% Innovation: 12 product lines Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $12M | 20 mo ago | Series A | 15 | Anshumen Bhagat Founder & Chief Medical Officer | — | — | — |
| 25 | Chill Brands Group Brand of hemp extracts | $12M | 12 mo ago | Public | 5 | — | 5 signals ▲67% Earnings | — | — |
| 26 | Occuity Manufacturer of optical instruments for healthcare industry | $9M | 5 mo ago | Seed | 41 | Robin Taylor Chief Technology Officer And Founder | — | 34 patents Optical biometric devices for rapid, confocal eye measurements and handheld scanning | 2 awards |
| 27 | Signify Research Provider of healthcare technology market intelligence and research services | $8M | 20 mo ago | Series A | 29 | Simon Harris Chairman & Founder | — | — | — |
| 28 | NRG GYM Chain of fitness centers | $7M | 8 mo ago | Series A | 32 32 → 60 (+88%) · sector median +44% | Michael Enright Co-Founder | — | — | — |
| 29 | Goodrays Brand of cannabis gummies, oils, drinks, and other products | $7M | 11 mo ago | Series A | 5 | — | — | — | — |
| 30 | AWAKN CRO focused on early stage clinical trial research | $6M | 15 mo ago | Acquired | 3 | — | — | — | — |
| 31 | Total Fitness Chain of fitness centers | $6M | 6 mo ago | Acquired | 600 | — | — | — | 1 award |
| 32 | Neupulse Provider of healthcare management services | $6M | 22 mo ago | Seed | 9 | Paul Cable CEO | — | — | — |
| 33 | DP Medical Supplier of medical equipment and instruments to ENT professionals | $6M | 22 mo ago | Early Stage | — | Douglas Pitman Founder | — | 33 patents Digital microscopy imaging hardware and AI-driven analysis for medical diagnostics | 1 launch |
| 34 | Ceryx Medical Association focusing on developing bioelectronics based on chip technology | $6M | 11 mo ago | Series A | 4 | Stuart Plant CEO | 4 signals Funding · Leadership | 23 patents Implantable cardiac pacing and patient monitoring systems | — |
| 35 | Apex Manufacturer of fitness equipments | $4M | 5 mo ago | Seed | 17 | Charlie Lucas Co-Founder | — | — | — |
| 36 | MI:RNA Diagnostics Standalone veterinary diagnostic testing laboratory | $4M | 6 mo ago | Series A | — | Eve Hanks Co-Founder & CEO | — | — | — |
| 37 | Tribe Manufacturer of natural energy protein bars, shakes, and muesli 29Growth top 35%Tech top 37%Funding bottom 45%Product bottom 39% All 7 signals ▾Growthtop 35% Techtop 37% Fundingbottom 45% Productbottom 39% Newsbottom 32% Globalbottom 32% Marketbottom 20% Growth: Fresh capital in last 24 mo Tech: 39 technologies across 4/8 capability areas · Cloud: Cloudflare, Heroku rank vs industry peers · Fliar Intelligence Index 29/100 | $4M | 17 mo ago | Seed | 8 | — | — | — | 1 partnership |
| 38 | ScubaTx Manufacturer of organ preservation devices | $4M | 21 mo ago | Seed | 8 | Leo Freitas Founder and Chief Information Officer | — | 4 patents Preservation systems for biological tissues and organs, enabling long‑term storage and transport. | — |
| 39 | Forge Genetics CRO focused on bioinformatics services | $3M | 8 mo ago | Seed | — | Nigel Minton Co-Founder | — | 7 patents Design and production of synthetic nucleic acid therapeutics and gene‑editing constructs | 1 job opening |
| 40 | Paloma Provider of NHS children’s autism assessments via remote and hybrid pathways | $3M | 19 mo ago | Seed | — | Mark Jenkins Co-Founder and CEO | — | — | 1 launch |
| 41 | NCIMB Provider of biorepository, microbial culture collection and microbiology services | $2M | 13 mo ago | Early Stage | 25 | — | — | 2 patents Enzymatic synthesis of cyclodextrins using cyclodextrin glucanotransferase | — |
| 42 | ImmuONE CRO focused on innovative solutions for inhalation safety | $2M | 15 mo ago | Seed | 8 | Abigail Martin Co-Founder & CEO | — | — | — |
| 43 | Fallouh Healthcare Standalone thoracic clinic | $1M | 12 mo ago | Funding Raised | 5 | — | — | — | — |
| 44 | Magnitude Biosciences Provider of cell-free in vitro assay for drug discovery companies | $1M | 12 mo ago | Seed | 12 12 → 20 (+67%) · sector median +44% | Fozia Saleem Chief Executive Officer | — | 2 patents Automated imaging and analysis systems for nematode behavior tracking | 1 partnership |
| 45 | Cosi Care Provider of itch relief products for eczema and other skin conditions | $1M | 6 mo ago | Seed | — | Lauren Bell Founder And Director | — | — | — |
| 46 | Punto Health Platform facilitating continuous support for patients, families, and providers to manage alzheimer's and… | $701K | 6 mo ago | Seed | — | Jack Eckersley Co-Founder | 5 signals ▲400% Funding | — | 1 job opening |
| 47 | Myomaker Bio Provider of preclinical muscle biology solutions, including research, screening, and development | $429K | 3 mo ago | Seed | — | Andrew Capel Co-Founder & Chief Scientific Officer | — | — | — |
| 48 | Until Provider of fitness and wellness services | $206K | 6 mo ago | Series A | 44 | Vishal Amin Founder & Chief Executive Officer | — | — | 1 partnership |
| 49 | TrueStart Coffee Provider of specialty coffee, emphasizing health benefits and sustainable practices 29Tech top 33%Talent top 38%Funding top 47%Moat top 48% All 8 signals ▾Techtop 33% Talenttop 38% Fundingtop 47% Moattop 48% Growthtop 50% Fin. healthbottom 40% Globalbottom 32% Marketbottom 21% Tech: 34 technologies across 5/8 capability areas · Cloud: Cloudflare Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 29/100 | $201K | 4 mo ago | Series A | 5 | Helena Hills Co-Founder & CEO | — | — | — |
| 50 | VerIQ Provider of clinical trial services for medical device and health technology | $135K | 5 mo ago | Seed | — | Andy Metcalfe Co-founder and Medical Director | — | — | — |
Top 12 Healthcare companies in United Kingdom
#1
Public · Cambridge, England · founded 1999 · 83100 employees$4.1Braised▾
Developer of pharmaceutical medicines for oncology and various chronic diseases. Research activities focus on the discovery and production of therapeutics targeting cancer, cardiovascular conditions, renal disorders, metabolic diseases, respiratory ailments, and immunological conditions. The business also develops treatments for rare diseases and infectious conditions. Operations involve clinical trials and the application of data science to identify new molecular entities for medical use.
- Jul 2025Grant (prize money)$6.1M
- Dec 2021Post IPO$6.1M
- May 2021Grant (prize money)$334.2K
- Jan 2021Grant (prize money)$371.8K
#2
Series A · Birkenhead, England · founded 2008 · 32 employees$21.6Mraised▾
Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services
- Feb 2026Grant (prize money)$303.2K
- Mar 2021Series A—
- Aug 2018Series A$4.5M
- Jul 2017Series A$2.1M
#3
Series B · England · founded 2015$20Mraised▾
Provider of consulting services to biopharma sector
- Mar 2026Series B$20M
#4
Public · Oxford, England · founded 1995 · 815 employees$149.7Mraised▾
Manufacturer of viral vectors for cell and gene therapy products. Services include process development, analytical methods, and manufacturing support for advanced therapy developers. Expertise spans lentivirus, adeno-associated virus, and adenovirus platforms to facilitate the development and production of therapeutic treatments.
- Aug 2025Post IPO$81.3M
- Jan 2025Post IPO—
- Sep 2021Post IPO$68.3M
- Apr 2019Unattributed—
#5
Public · York, England · founded 2008 · 151 employees$24.1Mraised▾
Developer of immunoassays for diagnostic purposes. It offers a rapid lateral flow immunoassay system that enables multiplexed immunodiagnostics. Its flagship product Seralite- FLC measures kappa (K) and lambda (λ) immunoglobulin-free light chain used for the detection of hematological cancers. It als provide research services for a range of sectors including the clinical point of care, clinical self-test, pharmaceutical, and others.
- Oct 2025Post IPO$4.4M
- Jan 2019Series A$2.6M
- Dec 2017Series A$1.5M
- Jul 2016Series A$3.9M
#6
Seed · Reading, England · founded 2019 · 41 employees$9.4Mraised▾
Manufacturer of optical instruments for healthcare industry
- Dec 2025Seed$1.8M
- Sep 2025Seed$105.8K
- Dec 2023Convertible Debt$1.7M
- Nov 2022Grant (prize money)$415.2K
#7
Funding Raised · Crumlin, Northern Ireland · founded 1982 · 200 employees$68.6Mraised▾
Randox Laboratories develops and markets instruments and assays for clinical diagnostics. It has an Rx series of analyzers that has semi-automated and fully automated solutions for clinical chemistry. It also has a range of reagents and biochip-based immunoassays for a wide range of therapeutic areas including immunology, oncology, metabolic, nutritional, cardiovascular, neurological, respiratory, toxicology and infectious diseases. In addition, the company provides molecular diagnostic services.
- Jul 2025Conventional Debt$67.9M
- Jan 2017Grant (prize money)$115K
- Mar 2016Grant (prize money)$213.6K
- Oct 2015Grant (prize money)$297.3K
#8
Acquired · United Kingdom · founded 1996 · 600 employees$5.9Mraised▾
Chain of fitness centers
- Dec 2025Conventional Debt$20.1M
- Jul 2023Conventional Debt$8.5M
- Sep 2018PE$5.9M
#9
Seed · London, England · founded 2019 · 17 employees$4.1Mraised▾
Manufacturer of fitness equipments
- Jan 2026Seed$565.9K
- Jan 2021Angel$4.1M
#10
Late Stage · Preston, England · founded 2019 · 66 employees$15.9Mraised▾
Panthera Bio is a clinical trials organization that provides dedicated clinical trial sites in the UK, delivering clinical trials and patient recruitment services to pharmaceutical and contract research organizations. The company aims to transform the North Texas Biotechnology industry by offering efficient R&D and validation services, ensuring rapid development and accelerated timelines. With a focus on patient recruitment and site management, Panthera Bio supports the development of new medicines and treatments.
- Aug 2025PE—
- Jul 2019Grant (prize money)$2M
- Jun 2019Grant (prize money)$600K
- May 2019Grant (prize money)$5.3M
#11
Series A · Gravesend, England · founded 2011 · 32 employees$7.4Mraised▾
Chain of fitness centers
- Oct 2025Conventional Debt$15.1M
- Jan 2025Series A$4.9M
- Mar 2018Series A$7.4M
#12
Series A · Edinburgh, Scotland · founded 2019$4Mraised▾
Standalone veterinary diagnostic testing laboratory
- Dec 2025Series A$3.6M
- Jun 2024Series A$4.4M
- 2023Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.